3 ASX shares I'd buy with $20,000 today

All these shares have a great potential upside ahead.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • Wisetech Global presents a buying opportunity with its logistics software and growth potential; despite a significant yearly drop, analysts project up to a 177.18% upside.
  • Pro Medicus is well-positioned for growth in medical imaging software, with analysts forecasting up to a 38.3% upside due to its strong business model and positive market sentiment.
  • DigiCo Infrastructure REIT, despite a substantial annual decline, is highlighted as a strong buy due to surpassing FY25 guidance, with Macquarie predicting a potential 67.74% upside.

If you have $20,000 to invest in ASX shares today, but don't know where to look, here are my three top picks.

A little boy surrounded by green grass and trees looks up at the sky, waiting for rain or sunshine.

Image source: Getty Images

Wisetech Global (ASX: WTC)

Wisetech shares closed 2.12% higher on Thursday afternoon, at $64.21 each. Over the past month the shares have dropped 22.62% and over the year they're down a painful 53.63%. 

The company provides logistics software that aims to improve the world's supply chains. Wisetech has a good growth pipeline, and I think this year's price plunge is the result of an overdone investor sell-off.  

Analysts think the company's share price will rebound too. Earlier this week, DP Wealth Advisory said it thinks the beaten-down tech stock as a buy. The broker said that long-term fundamentals and market leadership support a great buying opportunity for investors.

Bell Potter, Morgans, and Shaw and Partners' Jed Richards also all have a buy rating on the stock.

TradingView data shows that analysts forecast a maximum price target as high as $177.97. At the time of writing that implies the ASX 200 tech share has a potential upside of 177.18% over the next 12 months.

Pro Medicus (ASX: PME)

Meanwhile, the Pro Medicus share price closed 1.07% higher at $253.04 a piece on Thursday afternoon. The shares have dropped 11.79% over the past month but are still 17.9% higher than this time last year.

Pro Medicus specialises in advanced medical imaging software through its Visage platform. It enables radiologists to review scans with high speed and efficiency. The company has a growing recurring revenue, great margins and a ultra-light capital business model too, which means it's poised for strong growth. 

Analysts are very positive on the stock too with Pro Medicus shares making a few list of top-buys or ASX growth share picks. The team at Citi recently upgraded Pro Medicus to a buy rating with a $350.00 price target. Morgans has also upgraded Pro Medicus' shares to an accumulate rating with a slightly more bearish $290.00 price target. These price targets imply a potential 14.6% to 38.3% upside for investors over the next 12 months.

DigiCo Infrastructure REIT Stapled Securities (ASX: DGT)

For investors looking for exposure to Australia's hot property market without the risk, a real estate investment trust (REIT) with strong growth prospects is a sensible buy.

DigiCo's share price closed 3.33% higher on Thursday afternoon, at $2.48 a piece. That's a 12.06% drop over the month, and over the year, the shares are 50.4% lower thanks for a huge sell off in March.

On the surface the annual decline might look concerning, but I think it makes for a great buying opportunity. The company recently held a strong annual general meeting (AGM) and said it has surpassed guidance for FY25.

Macquarie thinks the low price presents a good buying opportunity, too. The broker has an outperform rating on the shares and a $4.16 target price. At the time of writing, that implies a potential 67.74% upside over the next 12 months.

Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended WiseTech Global. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended WiseTech Global. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Opinions

Woman staring at chocolate cake.
Opinions

I love Wesfarmers shares. Here's why I'm not buying more

According to Buffett, price and value are not the same.

Read more »

A woman looks shocked as she drinks a coffee while reading the paper.
Opinions

3 ASX stocks I'd buy during a sharemarket crash

Share market crashes could present a great buying opportunity for savvy investors.

Read more »

A man in a business suit covers his face with his hands as he stands under a storm cloud emitting heavy rain on top of him.
Opinions

5 tips to navigate ASX share market volatility

Hint: Avoid panic selling!

Read more »

A woman puts money in her piggy bank all rugged up for the winter cold.
Opinions

2 ASX shares I'd buy in June

Check out these winter warmers!

Read more »

Three business people look stressed as they contemplate stacks of extra paperwork.
Opinions

2 ASX 200 shares I'd buy and 1 I'd sell this month

These are the ASX 200 shares on my radar this month.

Read more »

Woman using a pen on a digital stock market chart in an office.
Opinions

2 ASX 200 shares I think could beat the market over 10 years

A decade is a long time in the market, but I think these ASX 200 shares have the quality to…

Read more »

Happy couple doing online shopping.
Opinions

Down 17%: Why I'd buy and hold Wesfarmers shares

Bunnings remains the key asset, but I think Wesfarmers has more than one way to create value over time.

Read more »

Opinions

2 top ASX shares to buy and hold for the next decade

I’m backing these investments to deliver big returns!

Read more »